Yan Shi (Shi Yan)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Venues

American journal of hematology

Journal of translational internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Shi, Hu Zhou, Ruibin Huang, Fang Wang, Heng Mei, Lie Lin, Jingming Guo, Xin Zhou, Zhenyu Li, Yaorong Liu, Sichen Li, Wei Zhou, Yu Hou, Ming Hou
A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia. American journal of hematology (2024)
Yan Shi, Hu Zhou, Ruibin Huang, Fang Wang, Heng Mei, Lie Lin, Jingming Guo, Xin Zhou, Zhenyu Li, Yaorong Liu, Sichen Li, Wei Zhou, Yu Hou, Ming Hou
A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia. American journal of hematology 99 (7) (2024)
Yan Shi, Hu Zhou, Ruibin Huang, Fang Wang, Heng Mei, Lie Lin, Jingming Guo, Xin Zhou, Zhenyu Li, Yaorong Liu, Sichen Li, Wei Zhou, Yu Hou, Ming Hou
A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia. American journal of hematology 99 (7) (2024)
Hu Zhou, Shouqing Han, Jie Jin, Ruibin Huang, Xinhong Guo, Xuliang Shen, Binghua Wang, Xin Wang, Hongxia Yao, Xin Du, Meijuan Huang, Xuehong Ran, Wei Wang, Tonghua Yang, Feng Zhang, Changcheng Zheng, Xuelan Zuo, Rong Fu, Da Gao, Zheng Ge, Ying Han, Yujie Li, Xiaoyan Kang, Yan Shi, Ming Hou
Efficacy and safety of QL0911 in adult patients with chronic primary immune thrombocytopenia: A multicenter, randomized, double-blind, placebo-controlled, phase III trial. Journal of translational internal medicine 11 (4) (2023)
Hu Zhou, Shouqing Han, Jie Jin, Ruibin Huang, Xinhong Guo, Xuliang Shen, Binghua Wang, Xin Wang, Hongxia Yao, Xin Du, Meijuan Huang, Xuehong Ran, Wei Wang, Tonghua Yang, Feng Zhang, Changcheng Zheng, Xuelan Zuo, Rong Fu, Da Gao, Zheng Ge, Ying Han, Yujie Li, Xiaoyan Kang, Yan Shi, Ming Hou
Efficacy and safety of QL0911 in adult patients with chronic primary immune thrombocytopenia: A multicenter, randomized, double-blind, placebo-controlled, phase III trial. Journal of translational internal medicine 11 (4) (2023)
Xiaofei Ni, Daqi Li, Chenglu Yuan, Yafei Yu, Haoyi Wang, Lingjun Wang, Tianshu Yu, Ping Qin, Jun Peng, Ming Hou, Yan Shi, Yu Hou
Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled study. American journal of hematology 97 (4) (2022)

Yan Shi.css-eqlu8i{font-size:small;padding-left:4px;} (Shi Yan)

Publication Activity (10 Years)

Top Topics

Top Venues

Yan Shi (Shi Yan)